PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

Webinar - 6.30am tomorrow, page-78

  1. 3,791 Posts.
    lightbulb Created with Sketch. 1554
    While the share price has dived, I’d say no, only because I can’t see their share price increasing rapidly and it would be unnecessary dilution. Would rather buy them for $100m (or whatever price it gets to) with less risk in 5 years when we have revenue.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.